Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Recurrence 1 Pancreatic Neoplasms 1 Nausea 1 Multiple Myeloma 1 Medulloblastoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Ependymoma 1

Interventions

Cyclophosphamide 6 Temozolomide 5 Etoposide 5 Vincristine 3 Radiotherapy 3 Cisplatin 3 lutetium Lu 177 dotatate 2 etoposide phosphate 2 Radiation 2 Filgrastim 2 Celecoxib 2 Carboplatin 2 sodium thiosulfate 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 abemaciclib 1 Topotecan 1 Thiotepa 1 Thalidomide 1 Tamoxifen 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × Thalidomide × Clear all

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡